CD44: structure, function and association with the malignant process D Naor, RV Sionov, D Ish-Shalom Advances in cancer research 71, 241-319, 1997 | 1352 | 1997 |
Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer JY Sagiv, J Michaeli, S Assi, I Mishalian, H Kisos, L Levy, P Damti, ... Cell reports 10 (4), 562-573, 2015 | 884 | 2015 |
The cellular response to p53: the decision between life and death RV Sionov, Y Haupt Oncogene 18 (45), 6145-6157, 1999 | 833 | 1999 |
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2 T Unger, T Juven‐Gershon, E Moallem, M Berger, RV Sionov, G Lozano, ... The EMBO journal, 1999 | 493 | 1999 |
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination D Naor, SB Wallach-Dayan, MA Zahalka, RV Sionov Hyaluronan in Cancer Biology, 127-146, 2009 | 440 | 2009 |
The multifaceted roles neutrophils play in the tumor microenvironment RV Sionov, ZG Fridlender, Z Granot Cancer microenvironment 8, 125-158, 2015 | 434 | 2015 |
Tumour suppression by p53: the importance of apoptosis and cellular senescence V Zuckerman, K Wolyniec, RV Sionov, S Haupt, Y Haupt The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 298 | 2009 |
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation Z Goldberg, RV Sionov, M Berger, Y Zwang, R Perets, RA Van Etten, ... The EMBO journal 21 (14), 3715-3727, 2002 | 258 | 2002 |
Mutations in serines 15 and 20 of human p53 impair its apoptotic activity T Unger, RV Sionov, E Moallem, CL Yee, PM Howley, M Oren, Y Haupt Oncogene 18 (21), 3205-3212, 1999 | 232 | 1999 |
Regulation of Bim in health and disease RV Sionov, SA Vlahopoulos, Z Granot Oncotarget 6 (27), 23058, 2015 | 219 | 2015 |
The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation I Louria-Hayon, T Grossman, RV Sionov, O Alsheich, PP Pandolfi, ... Journal of Biological Chemistry 278 (35), 33134-33141, 2003 | 182 | 2003 |
TRPM2 mediates neutrophil killing of disseminated tumor cells M Gershkovitz, Y Caspi, T Fainsod-Levi, B Katz, J Michaeli, S Khawaled, ... Cancer research 78 (10), 2680-2690, 2018 | 174 | 2018 |
Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis RV Sionov, O Cohen, S Kfir, Y Zilberman, E Yefenof The Journal of experimental medicine 203 (1), 189-201, 2006 | 166 | 2006 |
c-Abl neutralizes the inhibitory effect of Mdm2 on p53 RV Sionov, E Moallem, M Berger, A Kazaz, O Gerlitz, Y Ben-Neriah, ... Journal of Biological Chemistry 274 (13), 8371-8374, 1999 | 146 | 1999 |
c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination R Vogt Sionov, S Coen, Z Goldberg, M Berger, B Bercovich, Y Ben-Neriah, ... Molecular and cellular biology 21 (17), 5869-5878, 2001 | 135 | 2001 |
Targeting the holy triangle of quorum sensing, biofilm formation, and antibiotic resistance in pathogenic bacteria RV Sionov, D Steinberg Microorganisms 10 (6), 1239, 2022 | 120 | 2022 |
The regulation of pre-metastatic niche formation by neutrophils J Jablonska, S Lang, RV Sionov, Z Granot Oncotarget 8 (67), 112132, 2017 | 120 | 2017 |
Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis R Spokoini, S Kfir-Erenfeld, E Yefenof, RV Sionov Molecular endocrinology 24 (6), 1136-1150, 2010 | 99 | 2010 |
Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid‐induced apoptosis RV Sionov, R Spokoini, S Kfir‐Erenfeld, O Cohen, E Yefenof Advances in cancer research 101, 127-248, 2008 | 98 | 2008 |
A role for the polyproline domain of p53 in its regulation by Mdm2 M Berger, RV Sionov, AJ Levine, Y Haupt Journal of Biological Chemistry 276 (6), 3785-3790, 2001 | 87 | 2001 |